7 Root Causes of MCAS and Why Mold Is Number One

Last Updated: May 15, 2026

By: Brian Karr · Co-Founder & Chief Inspection Officer, We Inspect

Mast cell activation syndrome has seven root causes: mold and mycotoxin exposure, chronic infections, genetic mutations, gut dysbiosis, hormonal disruption, nervous system dysregulation, and chemical sensitization. Most people with MCAS have more than one active at the same time. Mold ranks first because it continuously re-activates the immune system from inside the home — around the clock, for as long as the source remains.

Mast cell activation syndrome (MCAS) is a condition in which the body’s mast cells become overreactive, releasing excessive amounts of histamine, prostaglandins, and other inflammatory mediators in response to triggers that wouldn’t normally provoke that level of response. Unlike mastocytosis (where mast cells proliferate abnormally), MCAS involves normal mast cell counts with dysfunctional behavior. The result is a multi-system condition affecting the skin, gut, lungs, brain, and cardiovascular system simultaneously.

MCAS used to be considered rare. The diagnosis now appears in functional medicine practices at a rate suggesting it has long been underrecognized — often dismissed as anxiety, food intolerance, or idiopathic inflammation for years before the correct diagnosis. Getting better requires identifying the trigger, not just managing the symptoms it produces. The seven causes below are not equally addressable. Some are genetic. Some are infection-driven. One is environmental, and it’s the one sitting inside most affected patients’ homes, largely undetected.

What Causes Mast Cells to Behave This Way?

Mast cells are sentinel immune cells found in nearly every tissue, with the highest concentrations in the gut, skin, lungs, and brain. Their job is to detect and respond to perceived threats by releasing a cascade of inflammatory signals. In a healthy system, that response is proportionate and temporary. In MCAS, the threshold for activation is too low. The cells fire too easily, too often, and in response to stimuli that shouldn’t produce that level of reaction.

What lowers the threshold? That’s the root cause question. A 2017 characterization of MCAS in the American Journal of the Medical Sciences identified multiple concurrent contributing factors in the majority of patients studied, confirming that MCAS is rarely driven by a single cause.¹ Identifying which causes are active is the only way to design a treatment strategy that resolves the condition rather than suppressing its output indefinitely.

Root Cause #1: Mold and Mycotoxin Exposure

Of all seven documented triggers, mold is the one most consistently missing from MCAS treatment plans. Not because the mechanism is disputed — the research is well-established — but because home environments are rarely included in the diagnostic workup.

A 2018 study in the Journal of Biological Regulators and Homeostatic Agents demonstrated that mold exposure directly activates the mast cell-cytokine immune response, driving release of IL-1, TNF-α, histamine, and prostaglandins.² A 2021 review in the International Journal of Molecular Sciences expanded on this, documenting how mycotoxins disrupt immune regulation through TLR4/NF-κB signaling, keeping mast cells in a state of sustained hyperactivation rather than episodic response.³ As Kraft, Buchenauer, and Polte documented in that review, mycotoxins “activate proinflammatory cytokines, especially from mast cells” through mechanisms that differ fundamentally from seasonal allergen exposure.

What gets missed isn’t the biology. It’s the delivery mechanism. Mold growing in wall cavities, crawlspaces, or HVAC coils doesn’t produce a single toxin exposure event. It produces a continuous one, every hour the person is in that building. Antihistamines manage what comes out of the mast cells. They don’t address what keeps triggering them.

I hear this pattern regularly on consultation calls. A dad in Denver reached out last month about his 8-year-old daughter, diagnosed with MCAS roughly two years after the family moved into their current home. They had been meticulous about food — tracking every reaction, keeping detailed logs. Nothing was consistent. Nobody had tested the crawlspace. The mold had been there since before they moved in. The home environment was never part of the workup. It almost never is.

The Other Six Root Causes of Mast Cell Activation

The following causes are all well-documented MCAS triggers. They frequently co-occur with mold exposure, which is part of why the clinical picture becomes so difficult to untangle without addressing each contributor separately.

Root Cause #2: Chronic Infections

Persistent bacterial, viral, and fungal infections can keep mast cells in a state of sustained activation. Borrelia burgdorferi, the bacterium responsible for Lyme disease, has been shown to directly induce mast cell degranulation and cytokine release in laboratory studies.⁴ Epstein-Barr virus, Bartonella, and candida overgrowth share a similar mechanism: the immune system stays in high-alert mode trying to contain the pathogen, and mast cells remain primed alongside it. Treating the infection addresses this trigger — but rarely resolves fully while an active environmental load is also present.

Root Cause #3: Somatic Genetic Mutations

A subset of MCAS patients carry identifiable mutations, most notably in the KIT gene (c-KIT/CD117), which regulates mast cell growth and activation signaling. These mutations lower the activation threshold, meaning the cells fire faster and harder in response to lower-level stimuli. Genetic predisposition doesn’t cause MCAS independently, but it creates vulnerability. In the presence of a concurrent trigger like mold or infection, genetically sensitized mast cells can drive significantly more severe and persistent reactions.

Root Cause #4: Gut Dysbiosis and Intestinal Permeability

The gut contains more mast cells than nearly any other organ. Dysbiosis, SIBO, and intestinal permeability create a chronic low-grade inflammatory environment that keeps gut-resident mast cells perpetually primed. The clinical overlap between MCAS, SIBO, and irritable bowel syndrome is substantial — and bidirectional. Mast cell mediators disrupt the intestinal lining, which worsens dysbiosis, which drives further mast cell activation. Addressing gut health is necessary but rarely sufficient on its own.

Root Cause #5: Hormonal Disruption

Estrogen directly lowers the mast cell activation threshold — which explains why many patients notice MCAS symptoms track closely with hormonal fluctuations: the menstrual cycle, perimenopause, and hormonal contraceptive use. This estrogen-mast cell relationship is documented at the receptor level. Mycotoxin exposure compounds this significantly. Zearalenone and other estrogenic mycotoxins produced by mold species common in water-damaged buildings have been shown to disrupt aromatase pathways and hormonal signaling in ways that amplify mast cell sensitization.⁵

Root Cause #6: Nervous System Dysregulation

The autonomic nervous system and mast cells operate in constant crosstalk. When the nervous system is locked in a chronic threat state — as seen in POTS, dysautonomia, and trauma-related sympathetic dominance — it signals mast cells to remain armed. This is why stress reliably worsens MCAS flares: the mechanism isn’t psychological, it’s neurobiological. Managing nervous system regulation reduces mast cell reactivity, but cannot resolve MCAS while an active environmental trigger continues signaling the same threat response.

Root Cause #7: Chemical Sensitization and Toxic Load

Volatile organic compounds, pesticides, solvents, and combustion byproducts have been associated with MCAS onset and flaring, particularly after an initial sensitization event. Once mast cells have been primed by another trigger — mold, infection, or genetic vulnerability — the threshold for chemical reactions drops further. Clinicians often describe this as total toxic load: the compounding effect of multiple simultaneous triggers on a mast cell population already near its reactivity ceiling. Reducing load means addressing each active trigger systematically, not in isolation.

Why Mold Creates a Problem the Other Causes Don’t

Six of the seven root causes can be tested for directly, treated medically, or at least identified through standard lab work. Mold is the exception. It’s invisible in routine diagnostic panels. It’s invisible in the structure of the building until specifically sampled. And it produces something no other MCAS trigger delivers at the same scale: direct mast cell degranulation through a continuous, around-the-clock exposure mechanism.

Adding to this: a 2011 study in the Journal of Immunology found that mycophenolic acid, produced by Penicillium molds common in water-damaged buildings, blocked B cell proliferation by more than 70% and completely inhibited immunoglobulin production at low concentrations.⁶ Mold doesn’t just trigger mast cells. It also suppresses the immune system’s capacity to recover from the activation.

The table below compares how each root cause behaves across three dimensions relevant to treatment.

What Changes When You Remove the Environmental Source

For mold-triggered MCAS, the clinical observation is consistent: treatment works better after the exposure stops. Antihistamines and mast cell stabilizers reduce the severity of reactions. They don’t address what keeps producing those reactions. Medications manage the output. They don’t address the input.

One patient described the logic clearly: “Until we’re out of the mold, I don’t want to waste testing for health on that kind of thing… until we know we’re out of the mold, we know our pathways can be cleansed, and we know we can start to heal.” That sequencing is correct. The body cannot begin to downregulate mast cell reactivity while continuously re-exposed to the trigger keeping it elevated.

Removing the environmental source doesn’t produce overnight remission. Mast cells that have been sensitized over months or years need time to recalibrate. But identifying the source removes the signal that has been keeping the immune system in a state of constant readiness. For patients who have spent years managing MCAS without identifying this trigger, finding it is often what makes everything else they’re doing finally start to work.

Key Takeaways

• MCAS has seven documented root causes; most patients have more than one active simultaneously, which is why single-trigger treatment strategies so often plateau.
• Mold and mycotoxin exposure ranks first because it creates continuous, direct mast cell activation that doesn’t pause while the source remains in the building.
• Standard MCAS workups rarely include environmental testing, leaving one of the most common and most actionable triggers unaddressed.
• Removing the environmental source is not a cure — but it removes the signal driving mast cell activation, which is what allows other treatments to produce durable results.

Seven causes means seven potential targets. The one that standard medicine consistently misses is the one that lives in the walls, under the floors, and inside the HVAC system. It doesn’t show up in tryptase levels. It shows up when someone tests the home.

Next Steps

If your MCAS treatment has produced only partial or inconsistent results, the environmental piece may be what’s missing. We Inspect uncovers hidden mold contamination through source-level Exposure Mapping™, ranks what’s genuinely driving your exposure, and delivers a contractor-ready Remediation Recovery Blueprint designed to reduce mycotoxin load — without recommending remediation we have any stake in. Get My Free Exposure Consultation

Frequently Asked Questions

What is the most common root cause of MCAS?

Mold and mycotoxin exposure is increasingly recognized as the most prevalent environmental root cause of MCAS. Research documents that mold directly activates the mast cell-cytokine immune response through TLR4 signaling, triggering histamine, prostaglandins, and other mediators. Its distinction from other causes is the delivery mechanism: continuous home exposure rather than episodic triggering events.

Can mold cause mast cell activation syndrome?

Mold does not produce MCAS in every exposed person, but it is a documented direct trigger for mast cell degranulation. In individuals with genetic susceptibility or existing sensitization from other causes, continuous mycotoxin exposure from a home environment can initiate MCAS or significantly worsen existing mast cell reactivity over time. The relationship is dose-dependent and cumulative.

How do I know if mold is triggering my MCAS?

The clearest indicator is pattern: symptoms that worsen at home and improve measurably after extended time away. Confirming it requires source-level environmental sampling, not air quality testing, which regularly misses mold growth hidden in walls, floors, and HVAC systems. A clinical mycotoxin urine test showing elevated exposure can point toward the home as the primary source.

Can MCAS go into remission once the root cause is removed?

Clinical observations consistently show that when the root cause is identified and eliminated, mast cell reactivity can stabilize significantly. This is most clearly documented in environmentally triggered cases, where removing from continuous mycotoxin exposure often leads to reduced reactivity over weeks to months. Full remission depends on how many concurrent root causes are active and how long exposure persisted.

What is the difference between a mold allergy and mold-triggered MCAS?

A mold allergy is an IgE-mediated response producing respiratory or skin symptoms tied to specific mold species. Mold-triggered MCAS is a broader immune dysregulation in which mycotoxins directly activate mast cells through non-IgE pathways, producing multi-system symptoms affecting the gut, skin, brain, lungs, and cardiovascular system simultaneously. Standard allergy panels will not detect mycotoxin-mediated MCAS.

References

1. Afrin LB, Molderings GJ, Fellinger H, et al. Characterization of mast cell activation syndrome. Am J Med Sci. 2017;353(3):207-215. PMID: 28262205
2. Kritas SK, Gallenga CE, D’Ovidio C, et al. Impact of mold on mast cell-cytokine immune response. J Biol Regul Homeost Agents. 2018;32(4):763-768. PMID: 30043558
3. Kraft S, Buchenauer L, Polte T. Mold, mycotoxins and a dysregulated immune system: a combination of concern? Int J Mol Sci. 2021;22(22):12269. doi:10.3390/ijms222212269
4. Talkington J, Nickell SP. Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun. 1999;67(3):1107-1115. PMCID: PMC96436
5. Alenazi A, Virk P, Almoqhem R, et al. The efficacy of hispidin and magnesium nanoparticles against zearalenone-induced fungal toxicity causing polycystic ovarian syndrome in rats. Biomedicines. 2024;12(5):943. doi:10.3390/biomedicines12050943
6. Karnell JL, et al. Mycophenolic acid differentially impacts B cell function depending on the activation signal. J Immunol. 2011;187(6):3300-3317. doi:10.4049/jimmunol.1003319

This article is for informational purposes only and does not constitute professional medical advice. If you believe mold or other environmental hazards may be affecting your health, consult your healthcare provider.